期刊
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY
卷 9, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fbioe.2021.748942
关键词
reprogramming; single cell genomics; regenerative medicine; cell fate; transcription factor
资金
- CPRIT [RP190451]
- NIH [DP2GM128203, UM1HG011996]
- Welch Foundation [I-1926-20170325]
- Burroughs Wellcome Fund [1019804]
- Green Center for Reproductive Biology
As we approach a comprehensive catalog of mammalian cell types, the ability to engineer specific cell types on demand would revolutionize biomedical research and regenerative medicine. Direct reprogramming of cells through specific transcription factor cocktails offers a promising strategy for cell fate engineering. Recent advancements in single-cell technologies have overcome challenges in bulk reprogramming methods, accelerating progress in the field of cellular engineering.
As we near a complete catalog of mammalian cell types, the capability to engineer specific cell types on demand would transform biomedical research and regenerative medicine. However, the current pace of discovering new cell types far outstrips our ability to engineer them. One attractive strategy for cellular engineering is direct reprogramming, where induction of specific transcription factor (TF) cocktails orchestrates cell state transitions. Here, we review the foundational studies of TF-mediated reprogramming in the context of a general framework for cell fate engineering, which consists of: discovering new reprogramming cocktails, assessing engineered cells, and revealing molecular mechanisms. Traditional bulk reprogramming methods established a strong foundation for TF-mediated reprogramming, but were limited by their small scale and difficulty resolving cellular heterogeneity. Recently, single-cell technologies have overcome these challenges to rapidly accelerate progress in cell fate engineering. In the next decade, we anticipate that these tools will enable unprecedented control of cell state.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据